GOUT AND HYPERURICEMIA
Clinical trials for GOUT AND HYPERURICEMIA explained in plain language.
Never miss a new study
Get alerted when new GOUT AND HYPERURICEMIA trials appear
Sign up with your email to follow new studies for GOUT AND HYPERURICEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a diabetes pill tame gout flares? new trial aims to find out
Disease control Not yet recruitingThis study tests whether empagliflozin, a drug currently used for diabetes, can lower uric acid levels and reduce inflammation in people with gout. About 60 adults with gout and high uric acid will receive either the drug or a placebo for 12 weeks. The goal is to see if this medi…
Matched conditions: GOUT AND HYPERURICEMIA
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 17, 2026 08:54 UTC
-
New gout pill aims to tame uric acid in Mid-Stage trial
Disease control Not yet recruitingThis study tests a new tablet called BR2251 to see if it can safely lower uric acid levels in people with gout and high uric acid. About 160 adults will receive either a low, medium, or high dose of BR2251 or a control drug for 12 weeks. The goal is to find the best dose to contr…
Matched conditions: GOUT AND HYPERURICEMIA
Phase: PHASE2 • Sponsor: BioRay Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Genetic screening could stop deadly drug reactions in gout patients
Prevention Not yet recruitingThis study in Vietnam tests whether checking a person's genes before starting the gout medicine allopurinol can prevent rare but life-threatening skin reactions. About 228 adults with gout will either get the genetic test or standard care, and their health will be tracked for one…
Matched conditions: GOUT AND HYPERURICEMIA
Phase: PHASE4 • Sponsor: Haiphong University of Medicine and Pharmacy • Aim: Prevention
Last updated May 17, 2026 08:49 UTC